Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
K‐M. Thoms, J. Baesecke, B. Emmert, J. Hermann, T. Roedling, P. Laspe, D. Leibeling, L. Truemper & S. Emmert. (2007) Functional DNA repair system analysis in haematopoietic progenitor cells using host cell reactivation. Scandinavian Journal of Clinical and Laboratory Investigation 67:6, pages 580-588.
Read now
Read now
Articles from other publishers (24)
Paulynn Suyin Chin & Constanze Bonifer. (2020) Modelling t(8;21) acute myeloid leukaemia ‐ What have we learned?. MedComm 1:3, pages 260-269.
Crossref
Crossref
Sayer Al-Harbi, Mahmoud Aljurf, Mohamad Mohty, Fahad Almohareb & Syed Osman Ali Ahmed. (2020) An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1. Blood Advances 4:1, pages 229-238.
Crossref
Crossref
Jean-Alain Martignoles, François Delhommeau & Pierre Hirsch. (2018) Genetic Hierarchy of Acute Myeloid Leukemia: From Clonal Hematopoiesis to Molecular Residual Disease. International Journal of Molecular Sciences 19:12, pages 3850.
Crossref
Crossref
Gene I. Uenishi, Ho Sun Jung, Akhilesh Kumar, Mi Ae Park, Brandon K. Hadland, Ethan McLeod, Matthew Raymond, Oleg Moskvin, Catherine E. Zimmerman, Derek J. Theisen, Scott Swanson, Owen J. Tamplin, Leonard I. Zon, James A. Thomson, Irwin D. Bernstein & Igor I. Slukvin. (2018) NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nature Communications 9:1.
Crossref
Crossref
Thomas H. Shin, Christopher Brynczka, Farshid Dayyani, Miguel N. Rivera & David A. Sweetser. (2016) TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia. Leukemia Research 48, pages 46-56.
Crossref
Crossref
Pierre Hirsch, Yanyan Zhang, Ruoping Tang, Virginie Joulin, Hélène Boutroux, Elodie Pronier, Hannah Moatti, Pascale Flandrin, Christophe Marzac, Dominique Bories, Fanny Fava, Hayat Mokrani, Aline Betems, Florence Lorre, Rémi Favier, Frédéric Féger, Mohamad Mohty, Luc Douay, Ollivier Legrand, Chrystèle Bilhou-Nabera, Fawzia Louache & François Delhommeau. (2016) Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia. Nature Communications 7:1.
Crossref
Crossref
Nicole Kohrs, Stephan Kolodziej, Olga N. Kuvardina, Julia Herglotz, Jasmin Yillah, Stefanie Herkt, Alexander Piechatzek, Gabriela Salinas Riester, Thomas Lingner, Christian Wichmann, Halvard Bonig, Erhard Seifried, Uwe Platzbecker, Hind Medyouf, Manuel Grez & Jörn Lausen. (2016) MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO. PLOS Genetics 12:3, pages e1005946.
Crossref
Crossref
D W L Chin, N Watanabe-Okochi, C Q Wang, V Tergaonkar & M Osato. (2015) Mouse models for core binding factor leukemia. Leukemia 29:10, pages 1970-1980.
Crossref
Crossref
I Leskov, C P Pallasch, A Drake, B P Iliopoulou, A Souza, C-H Shen, C D Schweighofer, L Abruzzo, L P Frenzel, C M Wendtner, M T Hemann & J Chen. (2012) Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies. Oncogene 32:8, pages 1066-1072.
Crossref
Crossref
Megan A. Hatlen, Lan Wang & Stephen D. Nimer. (2012) AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches. Frontiers of Medicine 6:3, pages 248-262.
Crossref
Crossref
Shinobu Matsuura, Ming Yan, Miao-Chia Lo, Eun-Young Ahn, Stephanie Weng, David Dangoor, Mahan Matin, Tsunehito Higashi, Gen-Sheng Feng & Dong-Er Zhang. (2012) Negative effects of GM-CSF signaling in a murine model of t(8;21)–induced leukemia. Blood 119:13, pages 3155-3163.
Crossref
Crossref
Björn SteffenMarkus KnopUlla BergholzOlesya VakhrushevaMiriam RodeGabriele KöhlerMarcel-Philipp HenrichsEtmar BulkSina HehnMartin StehlingMartin Dugas, Nicole BäumerPetra TschanterChristian BrandtsSteffen Koschmieder, Wolfgang E. BerdelHubert ServeCarol StockingCarsten Müller-Tidow. (2011) AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein. Blood 117:16, pages 4328-4337.
Crossref
Crossref
Fu-Sheng Chou, Mark Wunderlich, Andrea Griesinger & James C. Mulloy. (2011) N-RasG12D induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene. Blood 117:7, pages 2237-2240.
Crossref
Crossref
A. V. Rulina, P. V. Spirin & V. S. Prassolov. (2011) Activated leukemic oncogenes AML1-ETO and c-kit: Role in development of acute myeloid leukemia and current approaches for their inhibition. Biochemistry (Moscow) 75:13, pages 1650-1666.
Crossref
Crossref
D. Baskaran, P. V. Spirin & V. S. Prassolov. (2010) Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells. Molecular Biology 44:3, pages 369-379.
Crossref
Crossref
J A Kennedy & F Barabé. (2008) Investigating human leukemogenesis: from cell lines to in vivo models of human leukemia. Leukemia 22:11, pages 2029-2040.
Crossref
Crossref
Farshid Dayyani, Jianfeng Wang, Jing-Ruey J. YehEun-Young AhnErica Tobey, Dong-Er ZhangIrwin D. Bernstein, Randall T. PetersonDavid A. Sweetser. (2008) Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 111:8, pages 4338-4347.
Crossref
Crossref
Birte Niebuhr, Meike Fischer, Maike Täger, Jörg Cammenga & Carol Stocking. (2008) Gatekeeper function of the RUNX1 transcription factor in acute leukemia. Blood Cells, Molecules, and Diseases 40:2, pages 211-218.
Crossref
Crossref
Ondrej Krejci, Mark Wunderlich, Hartmut Geiger, Fu-Sheng Chou, David Schleimer, Michael Jansen, Paul R. Andreassen & James C. Mulloy. (2008) p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death. Blood 111:4, pages 2190-2199.
Crossref
Crossref
Kamaleldin E. Elagib & Adam N. Goldfarb. (2007) Oncogenic pathways of AML1-ETO in acute myeloid leukemia: Multifaceted manipulation of marrow maturation. Cancer Letters 251:2, pages 179-186.
Crossref
Crossref
J. A. Kennedy, F. Barabé, B. J. PattersonJ. Bayani, J. A. Squire, D. L. Barber & J. E. Dick. (2006)
Expression of TEL-JAK2 in primary human hematopoietic cells drives erythropoietin-independent erythropoiesis and induces myelofibrosis
in vivo
. Proceedings of the National Academy of Sciences 103:45, pages 16930-16935.
Crossref
Crossref
J Dunne, C Cullmann, M Ritter, N Martinez Soria, B Drescher, S Debernardi, S Skoulakis, O Hartmann, M Krause, J Krauter, A Neubauer, B D Young & O Heidenreich. (2006) siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts. Oncogene 25:45, pages 6067-6078.
Crossref
Crossref
Mark WunderlichOndrej KrejciJunping WeiJames C. Mulloy. (2006) Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability. Blood 108:5, pages 1690-1697.
Crossref
Crossref
Ming Yan, Eiki Kanbe, Luke F Peterson, Anita Boyapati, Yuqin Miao, Yang Wang, I-Ming Chen, Zixing Chen, Janet D Rowley, Cheryl L Willman & Dong-Er Zhang. (2006) A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nature Medicine 12:8, pages 945-949.
Crossref
Crossref